MedTech Innovator News

Program to Feature Best-in-Class Early Stage Companies Developing Biotechnology Products, Diagnostic and Drug Discovery Platforms, and Research and Development Services Read More →

Applications open now for May 12 first round pitch event WASHINGTON, March 23, 2021 /PRNewswire/ — Congenital heart disease (CHD) affects six out of 1,000 babies born in... Read More →

Letter from the CEO Signs are pointing to 2021 shaping up to be a GREAT year for medtech. Right out of the gate, CMS granted... Read More →

Letter from the CEO I’d like to remember 2020 as the year of the Breakthrough Device. As 2020 comes to a close, a topic that’s top... Read More →

“The MedTech Innovator Asia Pacific Showcase has demonstrated immense value in facilitating the introduction of the most promising Asia-based startups with potential investors and partners,” said Harjit Gill, CEO of APACMed. “Now in the program’s third year, APACMed is proud to support the team at MedTech Innovator as they aid in the advancement of companies dedicated to improving the standard of care in the Asia Pacific region. We look forward to following this year’s cohort and how each company is working to improve and prolong patient lives through innovation.” Read More →

Applications are reviewed by more than 200 executives and professionals from dozens of leading companies, including manufacturers, providers, and investors such as Johnson & Johnson, RCT Ventures, Baxter, Asahi Intecc, Edwards Lifesciences, Fujikura, NIPRO Medical Corp., Olympus Medical Systems Group, W.L Gore & Associates, Inc., and many more. Read More →

“Being part of the MedTech Innovator Asia Pacific Accelerator program has been a truly rewarding experience – not only because of the lessons we learned and the mentorship we received, but also because of the powerful network we were able to build,” said Dr. Sebastian Bhakdi, Founder and CEO of X-ZELL. Read More →

Based in Germany, cellvie is developing a device-enabled mitochondria transplantation therapy for heart disease. As winners of the Value Award competition, cellvie will receive a $25,000 non-dilutive cash prize and a profile in an upcoming issue of the MedTech Strategist. Read More →